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Patient not at goal for LDL-C
Further LDL reduction indicated clinically 
Increase statin dose
‘Rule of ‘6%’;Tolerability; Side effects
Combination therapy options
Statin + ezetimibe Additional 20-25% LDLc decrease
Target of <70mg/dl LDLc; <100mg/dl non-HDLc
Statin (+ Eze) + PCSK9i Additional 60% LDLc decrease
No target; maximise absolute risk reduction
ASCVD risk>3%/y; LDLc>100mg/dl 
ASCVD risk>2%/y; LDLc>140mg/dl
- Aggressive, established/ polyvascular CVD
- CVD, PAD, stroke
